HCA Healthcare, Inc.

NYSE:HCA

350.53 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993199219911990
Revenue 64,96860,23358,75251,53351,33646,67743,61441,49039,67836,91834,18233,01332,50630,68330,05228,37426,85825,47724,45523,50221,80819,72917,95316,67016,65718,68118,81919,90917,69511,13210,252761.6461272.6
Cost of Revenue 9,9029,3719,4818,3698,4817,7247,3166,9336,6386,2625,9705,7175,1794,96116,8264,6204,3954,3224,126000000000003,512230.5135.381.3
Gross Profit 55,06650,86249,27143,16442,85538,95336,29834,55733,04030,65628,21227,29627,32725,72213,22623,75422,46321,15520,32923,50221,80819,72917,95316,67016,65718,68118,81919,90917,69511,1326,740531.1325.7191.3
Gross Profit Ratio 0.8480.8440.8390.8380.8350.8350.8320.8330.8330.830.8250.8270.8410.8380.440.8370.8360.830.831111111111110.6570.6970.7070.702
Reseach & Development Expenses 0000000000000000000000000000000000
General & Administrative Expenses 29,48727,68526,77923,87423,56021,42520,05918,89718,11516,64115,64615,08913,44012,48411,95811,44010,71410,4099,928000000000000000
Selling & Marketing Expenses 0000000000000000000000000000000000
SG&A 29,48727,68526,77923,87423,56021,42520,05918,89718,11516,64115,64615,08913,44012,48411,95811,44010,71410,4099,9289,4198,6827,9527,2796,6396,7497,8117,6317,8427,10104,757452283.4162.2
Other Expenses -13,53514,12412,81412,02812,07710,886-466-43000000000000000000000000000
Operating Expenses 45,43941,80939,59335,90235,63732,31130,24128,35927,07525,09123,42022,48022,98921,5579,19420,81919,30518,07717,42520,79819,01117,68015,72815,44914,78616,85817,64816,75515,3439,6245,356490.3305.9174.1
Operating Income 9,6279,0989,7917,3167,2616,6426,1026,2526,0115,6084,8214,8524,5964,4474,0322,7003,1583,0782,5482,7162,9272,0682,3071,4002,2072,4761,7533,1542,3521,5082,66759.726.423.3
Operating Income Ratio 0.1480.1510.1670.1420.1410.1420.140.1510.1510.1520.1410.1470.1410.1450.1340.0950.1180.1210.1040.1160.1340.1050.1290.0840.1320.1330.0930.1580.1330.1350.260.0780.0570.085
Total Other Income Expenses Net 17-51842-1,886-2,01744814319-343-3412-1241,260163-43485247-462256-743-771-613-65-62-116-111-140-639-573-277-8557.738.417.7
Income Before Tax 7,7068,5809,8335,4305,2445,3354,3814,8103,9573,4812,9462,8943,5612,2312,0029411,1901,6612,1491,9732,1561,4551,5055161,2271,0813882,5151,7791,23196942.72513.5
Income Before Tax Ratio 0.1190.1420.1670.1050.1020.1140.10.1160.10.0940.0860.0880.110.0730.0670.0330.0440.0650.0880.0840.0990.0740.0840.0310.0740.0580.0210.1260.1010.1110.0950.0560.0540.05
Income Tax Expense 1,6151,7462,1121,0431,0999461,6381,3781,2611,1089508887196586272683166257257278246226022975705492061,01071548639416.89.83.7
Net Income 5,2425,6436,9563,7543,5053,7872,2162,8902,1291,8751,5561,6052,4651,2071,0546738741,0361,4241,2461,332833886219657379-3051,50596163050725.515.29.8
Net Income Ratio 0.0810.0940.1180.0730.0680.0810.0510.070.0540.0510.0460.0490.0760.0390.0350.0240.0330.0410.0580.0530.0610.0420.0490.0130.0390.02-0.0160.0760.0540.0570.0490.0330.0330.036
EPS 19.2419.4421.5111.110.2711.046.337.85.344.463.543.625.172.833.081.972.562.573.242.622.661.631.690.391.120.73-0.462.241.441.81.050.780.610.55
EPS Diluted 18.9619.1521.1610.9310.0710.665.957.34.994.163.373.494.972.763.021.932.512.533.182.582.611.591.650.391.110.73-0.462.221.431.81.030.780.610.55
EBITDA 12,72612,06712,64410,0379,8578,9498,2338,2187,9157,4286,5746,5316,0615,8685,4574,1164,5844,4693,9223,9664,0393,0783,3552,4333,3013,7232,9914,3093,3332,1172,06821.43.911.4
EBITDA Ratio 0.1960.20.2150.1950.1920.1920.1890.1980.1990.2010.1920.1980.1860.1910.1820.1450.1710.1750.160.1690.1850.1560.1870.1460.1980.1990.1590.2160.1880.190.2020.0280.0080.042